HOME >> BIOLOGY >> NEWS
Chromosome losses mean poor survival in childhood leukemia

COLUMBUS, Ohio A new international study of children with a severe form of acute lymphoblastic leukemia (ALL) shows that certain chromosome losses can signal an especially poor response to therapy, but that other chromosome abnormalities have no effect on treatment survial.

The finding should enable doctors to identify patients with severe ALL for additional or experimental therapies when such therapies become available. The study was published in the April issue of the journal Leukemia.

"Overall, we found that many chromosome abnormalities in our group of patients made no difference at all, although particular abnormalities could," says Dr. Nyla A. Heerema, a researcher with The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, and first author on the study.

"The results surprised us," she says. "We expected that additional chromosome abnormalities would mean a worse outcome."

The retrospective study involved 249 children diagnosed with ALL between 1986 and 1996 by 10 medical centers in the United States and five other countries. The children had received intensive chemotherapy and their disease had gone into complete remission.

All the children had cancers showing the Philadelphia chromosome, an alteration in the genes that indicates a poorer response to treatment. Sixty-one percent of the patients (153), showed secondary chromosome abnormalities; that is, abnormalities present in addition to the Philadelphia chromosome.

Heerema and her colleagues wanted to learn if secondary chromosome abnormalities contributed to a poor prognosis in children with ALL. They found that having most secondary chromosome abnormalities had little affect on a child's prognosis. It did, however, when they involved the loss of chromosome 7, or the part of it known as 7p, or the loss of a part of chromosome 9 known as 9p.

Among children with cancer c
'"/>

Contact: Darrell E. Ward
Ward-15@medctr.osu.edu
614-293-3737
Ohio State University
4-May-2004


Page: 1 2

Related biology news :

1. Chromosome caps predict bone marrow disease
2. Gene-rich human Chromosome 19 sequence completed
3. Chromosomes are nibbled before they fuse, researchers report
4. Chromosome assessment could predict increased risk of death from age-related disease
5. Chromosome centers defined and sequenced for model plant
6. Discovery: Chromosomes Found To End In Big Loops
7. UI Researchers Find Possible Genetic Link Between The X Chromosome And Ovarian Cancer
8. Counting X Chromosomes To Determine Sex
9. Genetic Code Of Chromosome Of Malaria Parasite Deciphered
10. Hopkins And International Team Maps First Major Cancer Gene To X Chromosome
11. UNC Scientists Succeed In Inserting Gene In Human Cells Via Artificial Chromosome

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/8/2019)... ... , ... PureWay, a healthcare-focused provider of sharps disposal, biohazard ... of sales and business development efforts, effective immediately. Mr. Kennedy will report directly ... Johnson & Johnson Medical, Globus Medical, WRP Asia Pacific, and Stryker, all where ...
(Date:1/7/2019)... ... January 07, 2019 , ... Concerto HealthAI, a ... precision health in oncology and other key therapeutic areas, and its Chief Executive ... entrepreneurs and executives spanning the entire healthcare landscape, on January 8, 2019, at ...
(Date:1/5/2019)... ... 04, 2019 , ... Join Bill Fox, Chief Strategy Officer, ... from MarkLogic – for a live webinar on Wednesday, January 16, ... using real world data for pharmacovigilance, and the implications of current inefficient data ...
Breaking Biology News(10 mins):
(Date:1/11/2019)... , ... January 11, 2019 , ... Drawing on over ... Tuesday, January 22, 2019 at 2:30pm EST will explore some of the key lessons ... of using one vendor vs. using multiple vendors, and find out how to ensure ...
(Date:1/8/2019)... ... January 07, 2019 , ... ... into Noninvasix. This represents the second investment AngelMD has made into Noninvasix in ... Noninvasix is developing a patient monitor to directly, accurately, and noninvasively measure brain ...
(Date:1/4/2019)... , ... January 01, 2019 , ... ... Microbiome Conference at the World Economic Forum Annual Meeting January 22-25, 2019 held ... is invitation-only. , The World Economic Forum Annual Meeting brings together leaders of ...
(Date:12/19/2018)... ... December 19, 2018 , ... R3 Stem Cell is ... Training Course in Las Vegas. Training includes facial rejuvenation, hair restoration and erectile ... nationwide for aesthetics, having the training from expert, Board Certified providers is critical ...
Breaking Biology Technology:
Cached News: